NEW YORK, Sept. 23, 2016 /PRNewswire/ -- Nadeem Faruqi, founding partner at Faruqi &
Faruqi, LLP, a leading national securities firm headquartered in
New York City, is investigating
the Board of Directors of Vitae Pharmaceuticals, Inc. ("Vitae" or
the "Company") (NASDAQ:VTAE) for potential breaches of fiduciary
duties in connection with the sale of the Company to Allergan plc
for approximately $639 million.
The Company's stockholders will only receive $21.00 in cash for each share of Company common
stock they own.
Click here for more information:
www.faruqilaw.com/VTAE. There is no cost or obligation to
you.
The investigation focuses on whether Vitae's Board of Directors
breached their fiduciary duties to the Company's stockholders by
failing to conduct a fair sales process and whether and by how much
this proposed transaction undervalues the Company to the detriment
of Vitae's shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The
firm is focused on providing exemplary legal services in complex
litigation in the areas of securities, shareholder, antitrust and
consumer litigation, throughout all phases of litigation. The
firm has an experienced trial team which has achieved significant
victories on behalf of the firm's clients. To keep track of the
latest securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity. Faruqi & Faruqi, LLP is working
together in this investigation with Juan E.
Monteverde from Monteverde & Associates PC.
If you own common stock in Vitae and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/VTAE or contact Nadeem Faruqi, Esq. either via e-mail at
nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212)
983-9330. You may also contact Juan E. Monteverde, Esq.
either via email at jmonteverde@monteverdelaw.com or by telephone
at (212) 971-1341.
Contact:
Faruqi & Faruqi, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Nadeem Faruqi, Esq.
nfaruqi@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330
Attorney Advertising. (C) 2016 Faruqi & Faruqi, LLP.
The law firm responsible for this advertisement is Faruqi &
Faruqi, LLP (www.faruqilaw.com). Prior results do not
guarantee or predict a similar outcome with respect to any future
matter. We are happy to discuss your particular case.
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vitae-shareholder-notice-faruqi--faruqi-llp-announces-the-investigation-of-vitae-pharmaceuticals-inc-vtae-over-the-proposed-sale-of-the-company-to-allergan-plc-300333491.html
SOURCE Faruqi & Faruqi, LLP
